Recent updates in the surgical treatment of colorectal cancer
| Autor: | Masashi Yamamoto, Kimihiro Yamashita, Tetsu Nakamura, Nobuhide Higashino, Shingo Kanaji, Satoshi Suzuki, Masayoshi Hosono, Yoshihiro Kakeji, Yoshiko Matsuda, Yasuo Sumi, Taro Oshikiri, Hiroshi Hasegawa, Takeru Matsuda |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Laparoscopic surgery
medicine.medical_specialty Colorectal cancer medicine.medical_treatment lateral pelvic lymph node dissection colorectal cancer Review Article Targeted therapy 03 medical and health sciences 0302 clinical medicine robotic surgery Medicine Robotic surgery Review Articles business.industry General surgery Gastroenterology medicine.disease Total mesorectal excision laparoscopic surgery Clinical trial Dissection transanal total mesorectal excision 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Surgery business Chemoradiotherapy |
| Zdroj: | Annals of Gastroenterological Surgery |
| ISSN: | 2475-0328 |
| Popis: | Because of recent advances in medical technology and new findings of clinical trials, treatment options for colorectal cancer are evolutionally changing, even in the last few years. Therefore, we need to update the treatment options and strategies so that patients can receive optimal and tailored treatment. The present review aimed to elucidate the recent global trends and update the surgical treatment strategies in colorectal cancer by citing the literature published in the last 2 years, namely 2016 and 2017. Although laparoscopic surgery is still considered the most common approach for the treatment of colorectal cancer, new surgical technologies such as transanal total mesorectal excision, robotic surgery, and laparoscopic lateral pelvic lymph node dissection are emerging. However, with the recent evidence, superiority of the laparoscopic approach to the open approach for rectal cancer seems to be controversial. Surgeons should notice the risk of adverse outcomes associated with unfounded and uncontrolled use of these novel techniques. Many promising results are accumulating in preoperative and postoperative treatment including chemotherapy, chemoradiotherapy, and targeted therapy. Development of new biomarkers seems to be essential for further improvement in the treatment outcomes of colorectal cancer patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text